Inovio Pharmaceuticals
INO
INO
174 hedge funds and large institutions have $99.8M invested in Inovio Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 49 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 30
49% less capital invested
Capital invested by funds: $197M → $99.8M (-$97.3M)
Holders
174
Holding in Top 10
–
Calls
$679K
Puts
$351K
Top Buyers
| 1 | +$1M | |
| 2 | +$966K | |
| 3 | +$861K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$623K |
| 5 |
Citigroup
New York
|
+$558K |
Top Sellers
| 1 | -$6.73M | |
| 2 | -$2.92M | |
| 3 | -$1.52M | |
| 4 |
Two Sigma Advisers
New York
|
-$1.06M |
| 5 |
Two Sigma Investments
New York
|
-$659K |